Related Experiment Video
Updated: Jul 14, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Are developing beta-adrenoceptors able to desensitize? Acute and chronic effects of beta-agonists in neonatal heart
J T Auman1, F J Seidler, C A Tate
1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
During fetal and neonatal development, beta-adrenergic receptors (beta-ARs) appear to be resistant to desensitization by beta-agonist drugs. To determine the mechanisms underlying the regulatory differences between adults and neonates, we administered isoproterenol, a mixed beta(1)/beta(2)-AR agonist, and terbutaline, a beta(2)-selective agonist. Effects were examined in the ensuing 4 h after a single injection, or after the last of four daily injections. We prepared cell membranes from heart (predominantly beta(1)-ARs) and liver (predominantly beta(2)-ARs) and assessed signal transduction in the adenylyl cyclase (AC) pathway. In the first few hours after a single administration of isoproterenol to adult rats, cardiac beta-ARs showed activation of G proteins (elevated AC response to forskolin) and desensitization of beta-AR-mediated responses; after the fourth injection, heterologous desensitization emerged, characterized by a loss of signaling mediated either through beta-ARs or glucagon receptors. Terbutaline evoked an increase in the forskolin response but no desensitization of receptor-mediated responses. When we gave the same treatments to neonatal rats, we observed cardiac G protein activation, but there was neither homologous nor heterologous desensitization of beta-ARs or glucagon receptors. In the adult liver, isoproterenol and terbutaline both failed to evoke desensitization, regardless of whether the drugs were given once or for 4 days. In neonates, however, acute or chronic treatment elicited homologous desensitization of beta-AR-mediated AC signaling, while sensitizing the response to glucagon. These results show that neonatal beta-ARs are inherently capable of desensitization in some, but not all, cell types; cellular responses can be maintained through heterologous sensitization of signaling proteins downstream from the receptor. Differences from adult patterns of response are highly tissue selective and are likely to depend on ontogenetic differences in subtypes of beta-ARs and AC.
Insights
Neonatal beta-adrenergic receptors (beta-ARs) show desensitization in some tissues, unlike adults. This suggests developmental differences in receptor regulation and signaling pathways.
Area of Science:
- Pharmacology
- Developmental Biology
- Molecular Biology
Background:
- Beta-adrenergic receptors (beta-ARs) are crucial for various physiological processes.
- During development, beta-ARs appear resistant to desensitization by beta-agonist drugs.
- Understanding these developmental differences is key to comprehending receptor regulation.
Purpose of the Study:
- To investigate the mechanisms behind the differing desensitization of beta-ARs in adult versus neonatal rats.
- To compare the effects of beta-agonist drugs on signal transduction in heart and liver tissues across age groups.
Main Methods:
- Administered isoproterenol (mixed beta(1)/beta(2)-AR agonist) and terbutaline (beta(2)-selective agonist) to adult and neonatal rats.
- Examined effects after single or multiple daily injections over 4 days.
- Assessed signal transduction in the adenylyl cyclase (AC) pathway using cell membranes from heart and liver.
Main Results:
- Adult cardiac beta-ARs desensitized after agonist exposure, with heterologous desensitization emerging after chronic treatment.
- Neonatal cardiac beta-ARs showed G protein activation but no homologous or heterologous desensitization.
- Adult liver beta-ARs did not desensitize in response to either agonist.
- Neonatal liver beta-ARs exhibited homologous desensitization with agonist treatment, alongside glucagon response sensitization.
Conclusions:
- Neonatal beta-ARs possess the intrinsic capacity for desensitization, but this is cell-type specific.
- Cellular responses can be sustained in neonates via heterologous sensitization of downstream signaling proteins.
- Observed differences between adult and neonatal responses are tissue-selective and influenced by ontogenetic variations in beta-AR subtypes and AC signaling.
Related Concept Videos
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Types of β-Blockers

